Real-World Cost Savings Demonstrated by Switching Patients with Refractory Diabetic Macular Edema to Intravitreal Fluocinolone Acetonide (Iluvien): A Retrospective Cost Analysis St...

por Ch’ng, Soon W., Brent, Alexander J., Empeslidis, Theodoros, Konidaris, Vasileios, Banerjee, Somnath
Publicado 2017

Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion

por Konidaris, Vasileios E., Tsaousis, Konstantinos T., Anzidei, Rossella, de la Mata, Guillermo, Brent, Alexander J.
Publicado 2018